A toolkit created by industry clinicians aims to help long-term care operators address questions about getting vaccinated. A PowerPoint presentation is available to share with staff and residents.
The federal government’s decision to allow Medicare coverage of monoclonal antibody therapy for COVID-19 treatments could be extremely helpful for nursing homes care for symptomatic, positive residents, according to a top expert.
Federal agencies say they will depend on clinician input during distribution of Eli Lilly’s new intravenous antibody therapy for high-risk COVID-19 patients.
“This is the right therapy, but it needs more study … and it needs engaged medical director oversight and supervision,” says AMDA’s Executive Director Chris Laxton. Emergency approval of COVID antibody therapy is predicted in the coming weeks.
The COVID-19 pandemic is causing fears, anxieties and uncertainties for everyone, and these feelings can manifest in anger and rage. Physicians and other practitioners are often the target of these tirades, and they need to be prepared to deal with them. But, at the same time, there are some efforts they can take to prevent…
Post-acute and long-term care providers have an additional tool on how to adjust their operations and standards of care during the COVID-19 pandemic or future emergencies.
The Centers for Medicare & Medicaid Service’s response to a highly anticipated report by the Coronavirus Commission on Safety and Quality in Nursing Homes has been disappointing for one long-term care provider advocacy group.
Nursing home operators took limiting in-person contact with residents very seriously after the onset of the coronavirus pandemic. Visits of all kinds fell by 53% between March and April, new findings by SeniorLiving.org Research revealed.
The first national organization to officially endorse the adoption of a national Physician Orders for Life-Sustaining Treatment (POLST) form has emerged.
A nationally recognizable POLST form would give seriously ill or frail seniors the ability to communicate treatment preferences across care settings, the organization says.
